Catalyst

Slingshot members are tracking this event:

Phase 1/2 data of Selinexor - STOMP trial for Multiple Myeloma

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
KPTI

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 1/2 Data, Selinexor, Stomp Trial, Multiple Myeloma